APA Citation

Follows, R. M., Snowise, N. G., Ho, S., Ambery, C. L., Smart, K., & McQuade, B. A. (2013). Efficacy, safety and tolerability of GSK2190915, a 5-lipoxygenase activating protein inhibitor, in adults and adolescents with persistent asthma: A randomised dose-ranging study. BioMed Central.

Citação norma Chicago

Follows, Richard MA, Neil G. Snowise, Shu-Yen Ho, Claire L. Ambery, Kevin Smart, and Barbara A. McQuade. Efficacy, Safety and Tolerability of GSK2190915, a 5-lipoxygenase Activating Protein Inhibitor, in Adults and Adolescents With Persistent Asthma: A Randomised Dose-ranging Study. BioMed Central, 2013.

MLA Citation

Follows, Richard MA, et al. Efficacy, Safety and Tolerability of GSK2190915, a 5-lipoxygenase Activating Protein Inhibitor, in Adults and Adolescents With Persistent Asthma: A Randomised Dose-ranging Study. BioMed Central, 2013.

Advarsel: Disse citationer er muligvist ikke 100% nøjagtige.